{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:14:16Z","timestamp":1776435256807,"version":"3.51.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>\n                    Early cancer detection remains a major challenge in veterinary medicine. Cell-free DNA (cfDNA), released into the bloodstream through apoptosis, necrosis, or circulating tumor cells, can be quantified non-invasively via liquid biopsy and is already established in human oncology. In this study, we evaluated OncoCan, a targeted plasma cfDNA assay, by analyzing samples from 83 dogs with various neoplasms and 47 healthy controls to assess diagnostic and prognostic utility. Wilcoxon rank-sum testing revealed significantly higher cfDNA concentrations in neoplastic versus healthy samples (\n                    <jats:italic>p<\/jats:italic>\n                    \u202f=\u202f4.45e\u201307). ROC curve analysis demonstrated high accuracy for lymphomas\/leukemias (AUC\u202f=\u202f0.95) and moderate accuracy for carcinomas (AUC\u202f=\u202f0.75), sarcomas (AUC\u202f=\u202f0.76), and melanomas (AUC\u202f=\u202f0.69). Stratification by histological grade and clinical stage further supported cfDNA\u2019s predictive capability. Three practical thresholds were established: &amp;lt;50\u202fpg\/\u03bcL to distinguish healthy from neoplastic cases; \u2265100\u202fpg\/\u03bcL as a \u201chigh positive\u201d threshold indicating aggressive disease; and \u2265300\u202fpg\/\u03bcL as a \u201cvery high positive\u201d threshold strongly associated with systemic dissemination, high-grade histology, and poor survival. The &amp;lt;50\u202fpg\/\u03bcL cut-off showed robust diagnostic performance (AUC\u202f=\u202f0.808, sensitivity\u202f=\u202f82%, specificity\u202f=\u202f73%), confirmed by survival analysis and hazard ratio modeling. These findings suggest that OncoCan provides a noninvasive, clinically applicable tool for cancer prognosis in dogs. Validation in larger cohorts is warranted to support its integration into routine veterinary oncology practice.\n                  <\/jats:p>","DOI":"10.3389\/fvets.2026.1768078","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:46:11Z","timestamp":1771861571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["OncoCan: a liquid biopsy assay for cell-free DNA quantification in canine plasma to support cancer prognosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Virginia","family":"S\u00e1nchez","sequence":"first","affiliation":[{"name":"Complutense Veterinary Teaching Hospital and Department of Animal Medicine and Surgery, Veterinary Medicine School, Complutense University of Madrid","place":["Madrid, Spain"]},{"name":"Clinica Veterinaria Alameda","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal.la","family":"Farreny","sequence":"additional","affiliation":[{"name":"Omica Biomed","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Martinez-Merlo","sequence":"additional","affiliation":[{"name":"Complutense Veterinary Teaching Hospital and Department of Animal Medicine and Surgery, Veterinary Medicine School, Complutense University of Madrid","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Trancon","sequence":"additional","affiliation":[{"name":"Complutense Veterinary Teaching Hospital and Department of Animal Medicine and Surgery, Veterinary Medicine School, Complutense University of Madrid","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos","family":"Monta\u00f1\u00e9s","sequence":"additional","affiliation":[{"name":"Molecular Biology Core, Hospital Cl\u00ednic of Barcelona","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Enriquez","sequence":"additional","affiliation":[{"name":"Omica Biomed","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantxa","family":"Aguirrebe\u00f1a","sequence":"additional","affiliation":[{"name":"Omica Biomed","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Arasanz Duque","sequence":"additional","affiliation":[{"name":"Omica Biomed","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Noce","sequence":"additional","affiliation":[{"name":"Omica Biomed","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/vco.12839","article-title":"Lifetime prevalence of malignant and benign tumours in companion dogs: cross-sectional analysis of dog aging project baseline survey","volume":"20","author":"Schwartz","year":"2022","journal-title":"Vet Comp Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jvim.16616","article-title":"Cancer detection in clinical practice and using blood-based liquid biopsy: a retrospective audit of over 350 dogs","volume":"37","author":"Flory","year":"2023","journal-title":"J Vet Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fvets.2016.00087","article-title":"The current state of clinical application of serum biomarkers for canine lymphoma","volume":"3","author":"Bryan","year":"2016","journal-title":"Front Vet Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/jvim.13954","article-title":"Thymidine kinase type 1 and C-reactive protein concentrations in dogs with spontaneously occurring cancer","volume":"30","author":"Selting","year":"2016","journal-title":"J Vet Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/vco.12848","article-title":"Blood biomarkers for canine cancer, from human to veterinary oncology","volume":"20","author":"Colombe","year":"2022","journal-title":"Vet Comp Oncol"},{"key":"ref6","first-page":"199","article-title":"Clinical use of molecular biomarkers in canine and feline oncology: current and future","volume":"11","author":"Aupperle-Lellbach","year":"2024","journal-title":"Vet Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tvjl.2010.04.005","article-title":"Biomarkers in veterinary cancer screening: applications, limitations and expectations","volume":"185","author":"Henry","year":"2010","journal-title":"Vet J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12917-022-03429-8","article-title":"Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs","volume":"18","author":"Wilson-Robles","year":"2022","journal-title":"BMC Vet Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e61449","DOI":"10.3791\/61449-v","article-title":"Detection of cell-free DNA in blood plasma samples of cancer patients","volume":"163","author":"Palande","year":"2020","journal-title":"J Vis Exp"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","article-title":"Evaluation of cell-free DNA approaches for multi-cancer early detection","volume":"40","author":"Jamshidi","year":"2022","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.1038\/s41467-022-35320-3","article-title":"Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e006284","DOI":"10.1136\/jitc-2022-006284","article-title":"Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA","volume":"11","author":"Semenkovich","year":"2023","journal-title":"J Immunother Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41416-021-01696-0","article-title":"Cell-free DNA analysis in current cancer clinical trials: a review","volume":"126","author":"Cisneros-Villanueva","year":"2022","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1385041","DOI":"10.3389\/fcell.2024.1385041","article-title":"The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples","volume":"12","author":"Peng","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1177\/1040638719880245","article-title":"Quantification of plasma cell-free DNA levels in dogs with various tumors","volume":"31","author":"Tagawa","year":"2019","journal-title":"J Vet Diagn Invest"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"735682","DOI":"10.3389\/fvets.2021.735682","article-title":"Cell-free DNA as a diagnostic and prognostic biomarker in dogs with tumors","volume":"8","author":"Kim","year":"2021","journal-title":"Front Vet Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1489402","DOI":"10.3389\/fvets.2024.1489402","article-title":"Early detection of canine hemangiosarcoma via cfDNA fragmentation and copy number alterations in liquid biopsies using machine learning","volume":"11","author":"Ko","year":"2025","journal-title":"Front Vet Sci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1177\/0300985821999831","article-title":"Review of histological grading systems in veterinary medicine","volume":"58","author":"Avallone","year":"2021","journal-title":"Vet Pathol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/0300985816638721","article-title":"Cytologic criteria for mast cell tumor grading in dogs with evaluation of clinical outcome","volume":"53","author":"Camus","year":"2016","journal-title":"Vet Pathol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recogn Lett"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"ref24","author":"Therneau","year":"2015"},{"key":"ref25","year":""},{"key":"ref26","doi-asserted-by":"publisher","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fgene.2020.00280","article-title":"Sequencing shorter cfDNA fragments decreases the false negative rate of non-invasive prenatal testing","volume":"11","author":"Xue","year":"2020","journal-title":"Front Genet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0266623","DOI":"10.1371\/journal.pone.0266623","article-title":"Clinical validation of a next-generation sequencing-based multi-cancer early detection \u201cliquid biopsy\u201d blood test in over 1,000 dogs using an independent testing set: the CANcer detection in dogs (CANDiD) study","volume":"17","author":"Flory","year":"2022","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1182093","DOI":"10.3389\/fvets.2023.1182093","article-title":"Clinical utility of liquid biopsy in canine oral malignant melanoma using cell-free DNA","volume":"10","author":"Tagawa","year":"2023","journal-title":"Front Vet Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/vco.12961","article-title":"Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping","volume":"22","author":"Kambayashi","year":"2024","journal-title":"Vet Comp Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.xcrm.2023.101349","article-title":"Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis","volume":"5","author":"Moldovan","year":"2024","journal-title":"Cell Rep Med"},{"key":"ref32","year":""}],"updated-by":[{"DOI":"10.3389\/fvets.2026.1826236","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000}}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1768078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:36:14Z","timestamp":1776432974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1768078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":32,"alternative-id":["10.3389\/fvets.2026.1768078"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1768078","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"article-number":"1768078"}}